U.S. Markets open in 9 hrs 21 mins

BG Medicine, Inc. (BGMD)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.061+0.00 (+1.67%)
At close: 3:39PM EDT
People also watch
ABIOCEREACURAVEOATOS

BG Medicine, Inc.

303 Wyman Street
Suite 300
Waltham, MA 02451
United States
781-890-1199
http://www.bg-medicine.com

SectorHealthcare
IndustryMedical Laboratories & Research
Full Time Employees5

Key Executives

NameTitlePayExercisedAge
Dr. Paul R. Sohmer M.D.Chief Exec. Officer, Pres and Director429.17kN/A68
Mr. Stephen P. HallChief Financial Officer, Exec. VP and Treasurer351.03kN/A66
Dr. Aram Adourian Ph.D.Chief Scientific Officer and Sr. VP275kN/A47
Dr. Noubar B. Afeyan Ph.D.FounderN/AN/A54
Amounts are as of December 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

BG Medicine, Inc. engages in development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke. It has license, development, and commercialization agreements with Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc. for the automated instrument versions of galectin-3 test; and a strategic collaboration with Abbott Laboratories to develop and commercialize galectin-3 assay kits, and related control kits and calibrators. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts.

Corporate Governance

BG Medicine, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.